A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Ming Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Pharmacy, Guilin Normal College, Guilin, 541004, China. Hauptthemen laut MEDLINE: RNA, Small Interfering, Theranostic Nanomedicine, Genetic Therapy, RNA, Messenger. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundations of China, Natural Science Foundations of Guangxi Province, Guangxi University Young and Middle-aged Teachers Research Basic Capacity Improvement Project.
Abstract (Originalsprache)
Despite the significant potential of short hairpin RNA (shRNA)‐mediated gene therapy for various diseases, the clinical success of cancer treatment remains poor, partly because of low selectivity and low efficiency. In this study, an mRNA‐initiated autonomous multi‐shRNA nanofactory (RNF@CM) is designed for in vivo amplification imaging and precise cancer treatment. The RNF@CM consists of a gold nanoparticle core, an interlayer of two types of three‐stranded DNA/RNA hybrid probes, one of which is bound to aptamer‐inhibited DNA polymerases, and an outer layer of the cancer cell membrane. After the specific delivery of RNF@CM into target cancer cells, an intracellular tumour‐related mRNA target can initiate the RNF@CM with a circular strand‐displacement polymerisation reaction, resulting in the release of significantly amplified fluorescence and continuous production of three types of shRNAs. The RNF@CM effectively distinguished cancer cells from normal cells, exclusively produced multiple shRNAs in response to a specific mRNA target in cancer cells, accurately diagnosed tumours in vivo, and significantly inhibited tumour growth with negligible toxicity, expanding the toolbox for on‐demand gene delivery and precision theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Pharmacy, Guilin Normal College, Guilin, 541004, China.
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, China.
- Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, Yulin, 537000, China.
ORCID-Profile: Jiayao Xu
Förderung
- National Natural Science Foundations of China
- Natural Science Foundations of Guangxi Province
- Guangxi University Young and Middle-aged Teachers Research Basic Capacity Improvement Project
Zitieren
APA
Shi, M., He, Y., Zhong, X., Huang, H., Hua, J., Wang, S., Xu, J., Zhao, S., Liang, H., & Huang, Y. (2025). A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404159
Vancouver
Shi M, He Y, Zhong X, Huang H, Hua J, Wang S, et al. A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404159
BibTeX
@article{Shi2025,
author = {Shi, Ming and He, Yifang and Zhong, Xiaohong and Huang, Huakui and Hua, Jing and Wang, Shulong and Xu, Jiayao and Zhao, Shulin and Liang, Hong and Huang, Yong},
title = {A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404159}
}
EUVIMED